Using pharmacotherapy to address sleep disturbances in autism spectrum disorders
Expert Rev Neurother. 2023 Jul-Dec;23(12):1261-1276. doi: 10.1080/14737175.2023.2267761. Epub 2023 Dec 15.ABSTRACTINTRODUCTION: Sleep disorders are the second most common medical comorbidity in autism spectrum disorder (ASD), with effects on daytime behavior and functioning, mood and anxiety, and autism core features. In children with ASD, insomnia also has a negative impact on the whole family's quality of life. Therefore, treatment of sleep disturbances should be considered as a primary goal in the management of ASD patients, and it is important to clarify the scientific evidence to inappropriate treatments.AREAS COVERED...
Source: Expert Review of Neurotherapeutics - October 9, 2023 Category: Neurology Authors: Valeria Mammarella Silvia Orecchio Noemi Cameli Sara Occhipinti Lavinia Marcucci Giuliano De Meo Alice Innocenti Raffaele Ferri Oliviero Bruni Source Type: research
